找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Inflammation in Health and Disease, Volume I; Yong-Xiao Wang Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusi

[復(fù)制鏈接]
樓主: Neogamist
51#
發(fā)表于 2025-3-30 11:25:49 | 只看該作者
52#
發(fā)表于 2025-3-30 16:09:18 | 只看該作者
Innate Lymphoid Cells in Airway Inflammation,elevation of IL-4, IL-5 and IL-13 and other inflammatory mediators, leading to increased eosinophilic inflammation. The growing evidence of ILC2 contribution in the induction and maintenance of allergic inflammation suggests that targeting upstream mediators may affect both the innate and adaptive i
53#
發(fā)表于 2025-3-30 19:39:35 | 只看該作者
54#
發(fā)表于 2025-3-30 22:18:59 | 只看該作者
55#
發(fā)表于 2025-3-31 03:17:01 | 只看該作者
Sex-Steroid Signaling in Lung Diseases and Inflammation,ry lung diseases and to understand the mechanistic role of sex-steroids signaling in regulating these diseases. Exploring the roles of sex-steroid signaling in the regulation of lung diseases and inflammation is crucial for the development of novel and effective therapy. Overall, we will illustrate
56#
發(fā)表于 2025-3-31 09:03:24 | 只看該作者
57#
發(fā)表于 2025-3-31 09:24:38 | 只看該作者
Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases,vival, cell cycle control, and inflammation, it is possible that the relationship between ROS and CaMKII/RyRs signal complex will be necessary for understanding and treating lung diseases. Here, we review roles of CaMKII/RyRs in lung diseases to understand with how CaMKII/RyRs may act as a transduct
58#
發(fā)表于 2025-3-31 14:32:52 | 只看該作者
59#
發(fā)表于 2025-3-31 18:30:42 | 只看該作者
Inflammation in Pulmonary Arterial Hypertension,d or skewed immune response favoring a proinflammatory environment that can lead to the infiltration of cells such as lymphocytes, macrophages, and neutrophils. Current treatment strategies focus on the dilation of partially occluded vessels; however, such techniques have not resulted in an effectiv
60#
發(fā)表于 2025-3-31 22:02:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 07:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长沙县| 闽侯县| 库车县| 霸州市| 英吉沙县| 元谋县| 临清市| 宣化县| 南投市| 兴隆县| 衡阳市| 湟源县| 闻喜县| 江达县| 淮安市| 汉川市| 织金县| 山丹县| 蒙城县| 南投市| 平罗县| 阿尔山市| 长岛县| 察雅县| 吴堡县| 承德县| 乌海市| 福清市| 洪洞县| 仙居县| 即墨市| 龙泉市| 景泰县| 鹤庆县| 察雅县| 新乡县| 西林县| 永城市| 宜阳县| 伊川县| 鸡泽县|